 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
Improving Radiation
Therapy for Cancer
with
ProACTiveTM (U.S. Patent # 7197404) |
|
AppCompTech is a software
development company focused on a
life sciences application in
Radiation Treatment Planning for
Cancer Therapy. In 2010 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy.
Our patented technology/software, called ProACTive™, shatters today’s industry-wide speed barrier to high accuracy dose calculation for radiation therapy. We blend incredible speed with accuracy, enabling adaptive planning for a significant competitive advantage over existing treatment technology. Adaptive planning with ProACTive can offer:
.
|
|
|
|
|
The AppCompTech/D3 Team |
KEYnotes Feature Article
- May 2010 |
(L-R) Steve Morrisson, Andy
Holland,
Greg Ross (D3), Dr. Marc
Sontag (D3),
Kathy Blum, and Jay
McClatchey.
Taken during ASTRO
2009
|
|
Applied Computational
Technologies in Final Prototype
Testing of Radiation Dose
Calculation Engine
Cancer treatment can be daunting.
Applied Computational Technologies
(ACT) works to make this process
easier for both patients and
radiation oncology professionals.
ACT’s software tool, ProACTive,
helps medical professionals
determine how best to plan a course
of treatment prescribed for a
patient.
Applied Computational
Technologies was founded in 2003 by
Jay McClatchey and Andy Holland. The
partners combined their backgrounds
in business, technology and
engineering to develop ProACTive, a
sophisticated software tool that
will dramatically improve the
radiation oncologist’s ability to
determine and implement the best
course of therapy for cancer
patients.
(Click here to read the entire
article) |
|
|
|
|
|
|
|
|
 |
 |
 |
|
